Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: Randomised placebo controlled trial

British Medical Journal

Volumn 332, Issue 7537, 2006, Pages 325-327

  Cohen, Alexander T ^a   Davidson, Bruce L ^b   Gallus, Alexander S ^c   Lassen, Michael R ^d   Prins, Martin H ^e   Tomkowski, Witold ^f   Turpie, Alexander G G ^d   Egberts, Jan F M ^g   Lensing, Anthonie W A ^g,h  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c FLINDERS MEDICAL CENTRE   (Australia)

^d Department of Clinical Research ^*  (Canada)

^e MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^f NATIONAL TUBERCULOSIS AND LUNG DISEASES RESEARCH INSTITUTE   (Poland)

^g Clinical Development Department   (Netherlands)

^h ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; FONDAPARINUX; PLACEBO;

ACUTE RESPIRATORY TRACT DISEASE; ADULT; AGED; ARTICLE; BED REST; BLEEDING; CHRONIC LUNG DISEASE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; EMERGENCY CARE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; INFECTION; INFLAMMATORY DISEASE; LEG PHLEBOGRAPHY; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; RISK REDUCTION; VENOUS THROMBOEMBOLISM;

ACUTE DISEASE; AGED; ANTICOAGULANTS; BED REST; CHRONIC DISEASE; DISEASE-FREE SURVIVAL; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HEMORRHAGE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; POLYSACCHARIDES; THROMBOEMBOLISM; TREATMENT OUTCOME; VENOUS THROMBOSIS;

EID: 32844466981     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.38733.466748.7C     Document Type: Article

References (15)

1. Cohen AT, Edmondson RA, Phillips MJ, Ward VP, Kakkar VV. The changing pattern of venous thromboembolic disease. Haemostasis 1996;26;65-71.
2. Ageno W, Squizzato A, Ambrosini F, Dentali F, Marchesi C, Mera V, et al. Thrombosis prophylaxis in medical patients: a retrospective review of clinical practice patterns. Haematologica 2002;87:746-50.
3. Alikhan R, Wilmott R, Agrawal S, Desouza N, Gera A, Zaw H, et al. Use of thromboprophylaxis in nonsurgical patients: survey of a London teaching hospital. Blood 2001;98:271a (abstract 1142).
4. Cohen AT. Venous thromboembolic disease management of the nonsurgical moderate- and high-risk patient. Semin Hematol 2000;37 (suppl.5):19-22.
5. Mismetti P, Laporte S. Thromboprophylaxis in acute medical patients: need for an implementation strategy. Haematologica 2002;87:673-5.
6. Hampton KK. Venous thromboembolic risk and prevention in acute medical illness. Int J Clin Pract 2003;57:424-7.
7. Samama MM, Cohen AT, Darmon JY, Desjardins L, Eldor A, Janbon C, et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill patients. N Engl J Med 1999;341:793-800.
8. Turpie AGG, Bauer KA, Eriksson BI, Lassen MR. Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery. A meta-analysis of 4 randomized double-blind studies. Arch Intern Med 2002;162:1833-40.
9. The Matisse Investigators. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism. N Engl J Med 2003;349:1695-702.
10. Geerts WH, Heit JA, Clagett GP, Pineo GF, Colwell CW, Anderson FA Jr, et al. Prevention of venous thromboembolism. Chest 2001;119:S132-75.
11. Mismetti P, Laporte-Simitsidis S, Tardy B, Cucherat M, Buchmuller A, Juillard-Delsart D, et al. Prevention of venous thromboembolism in internal medicine with unfractionated or low-molecular-weight heparins: a meta-analysis of randomized clinical trials. Thromb Haemost 2000;83:14-9.
12. Lindblad B, Sternby NH, Bergqvist D. Incidence of venous thromboembolism verified by necropsy over 30 years. BMJ 1991;302:709-11.
13. Sandler DA, Martin JF. Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis? J R Soc Med 1989;82:203-5.
14. Leizorovicz A, Cohen AT, Turpie AG, Olsson CG, Vaitkus PT, Goldhaber SZ, et al. A randomized placebo controlled trial of dalteparin for the prevention of venous thromboembolism in 3706 acutely ill medical patients: the PREVENT medical thromboprophylaxis study trial. Circulation 2004;110:8749.
15. Collins R, Scrimgeour A, Yusuf S, Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomised trials in general, orthopaedic, and urologic surgery. N Engl J Med 1988;318:1162-73.